Content of the study:
The medical laboratories market - France

Available languages


1.1 Definition and scope of the study

Medical biology laboratories, formerly called medical analysis laboratories, are places whose function is the realization of diagnoses and medical follow-ups from samples of various human biological fluids. They are managed by biologists.

The French market includes suppliers of reagents and consumables (gloves, masks, etc.), various laboratory groups, sampling sites, technical platforms and finally government agencies (the French Health Insurance).

The turnover of the activity in France has experienced strong growth thanks in particular to Covid PCR tests (120 million tests were performed between May 2020 and the end of 2022, generating strong revenues for the laboratories and representing 25% of the laboratories' turnover). This strong growth attracts many investors, such as Ardian or the BPI, who see a high profitability.

At the same time, the market is undergoing restructuring, the number of laboratories has dropped considerably over the last 10 years and mergers and acquisitions have multiplied. For example, in June 2022, Innovie acquired Biocolinic laboratories. Nevertheless, the number of sampling sites and the number of employees remain stable despite the rationalization of the sector.

In 2022 and 2023, the sector's revenue is down compared to 2020 and 2021 but should reach a level well above 2019.

In this context, where medical biology laboratories have benefited from strong revenues during the health crisis and where the Assurance Maladie has disbursed 7.3 billion euros to finance tests [Alternatives économiques], the Social Security financing bill for 2023 aims to reduce the fees for routine medical biology in order to achieve savings of 250 million euros. The announcement of this measure has led to strong tensions between the government and representatives of the sector.

1.2 Health expenditure in the EU

Europe presents a rather large panorama of medical biology laboratories. There are many differences between countries. These differences are reflected in the health care systems and the divergence in health care spending by European country.

An article from EM consulte provides a typology of health systems in Europe:

The Bismarckian wage-based ...

1.3 Medical laboratories in the consumption of medical care and goods

Each year, the Institute of Information and Professional Conjunctures (***) publishes a report on the Extra-Hospital Medical Biology Laboratories.

Similarly, each year the DREES publishes the results of the health accounts. The **** edition: Health spendings in **** reports and updates health data.

The annual reports of the I+C (***) and the DREES data ...

1.4 The profession's turnover

The latest I+C annual industry reports provide us with the evolution of the turnover of medical laboratories.

evolution of the turnover of medical laboratories (***) France, **** / **** - ****, billion euros Source: ****

Revenues have risen sharply in recent years after a stable period to reach €** billion in ****. This strong increase in revenue in ...

1.5 Biology laboratories in high demand in 2020

Analytical laboratories have been at the heart of the global pandemic. It is clear that they have not suffered too much from the crisis benefiting both from the continuity of activity even during containment but also from the increased demand for Covid-** testing.

The test was widely consumed during the year ...


2.1 Client profile and test use by disease

Biological tests throughout life

In December ****, Medicare published Benchmarks - Issue **, which conducts a focus on the medical biology sector in ****. According to this issue, in ****, a medical biology test was prescribed for nearly ** million people, or **% of the population.

Distribution of persons having had a medical biology analysis prescription by ...

2.2 The main prescribers of biological analyses

Benchmarks - Issue ** (***) also presents **** data for the most active private prescribers of medical biology procedures.

Source: ****

General practitioners are therefore the largest prescribers (***). Gynecologists, cardiologists, and anesthesiologists come next. It can be stated that the majority of procedures prescribed by general practitioners are low-cost procedures: in fact, they prescribe */* of ...

2.3 The star acts of the demand: amount and volume

The most reimbursed procedures in ****

The I+C branch report reveals the ** most reimbursed medical biology procedures in ****.

Source: ****

The top procedures in the ranking changes very little. The most reimbursed examinations are mainly Covid-** tests (***) and general check-ups such as haemograms and ionograms, which are blood tests.

For haemograms (***). In ...


3.1 Local sampling sites: a constant territorial network

The profession in the region includes all the local sampling sites and the laboratories that manage these sites. The sites are registered in the Insee nomenclature under the following NAF code, **.**B: Medical analysis laboratories .

The ACOSS database of the national URSSAF network allows us to obtain the evolution of the ...

3.2 Laboratories: mergers and rationalization of the sector, key players

Number of laboratories

The I+C industry report shows this decrease in the number of laboratories with at least one employee.

change in the number of laboratories (***) employing at least one employee France, **** - ****, in units Source: ****

Over the past ** years, the profession has restructured. Faced with the challenges of cost ...

3.3 Financing of medical biology laboratories

Overview and ****-**** changes in the financing of the CSBM for analysis laboratories

The financing of medical laboratories is provided by various actors: social security, complementary organizations and households. The table below shows the breakdown of the financing of the CSBM for analysis laboratories according to the various public and private ...

3.4 Salary structure

Gender of the workforce

The activity report of the sector conducted by the I+C in ****, allows us to approach the panorama of the number of employees in the sector in ****.

Breakdown of analysis laboratory employees by gender France, ****, in % Source: ****

The activity therefore employs a large majority of women. This ...

3.5 Business expenses: payroll and training

The wage bill

*.* billion in ****, i.e. **% of the profession's turnover. The proportion of laboratories with a profit-sharing agreement in **** is **% and **% of profit-sharing agreements have resulted in a payment.

Training expenses

The system that allows professionals in the sector to train their employees is the training plan. In ****, the ...


4.1 Breakdown of medical biology expenditure by pathology: a range of diagnostics

Benchmarks - Issue ** (***) presents medical biology expenditures by pathology

Breakdown of medical biology expenditures by pathology France, ****, in * or analgesic or anti-inflammatory treatment ** : with or without pathologies, treatments or maternity ***: chronic respiratory diseases (***). Source: ****

Nearly **% of laboratory spending is fairly generalist spending that is not related to a specific pathology. These ...

4.2 Evolution of the CSBM price index for medical analysis laboratories

The **** edition of the results of the health accounts (***) reports the evolution of the price index in the consumption of care and medical goods for analysis laboratories.

annual change in the CSBM price index for analysis laboratories France, ****-****, index *** in **** and % Source: ****

This index has therefore been falling steadily for ...

4.3 The two main types of laboratories

Two types of laboratories can be distinguished on the market:

Routine biology laboratories

These are the non-specialized laboratories that are the most present on the territory. Their role is to respond to a standard demand for medical analysis. These laboratories are often grouped around technical platforms. A place that gathers equipment ...


5.1 Legislative developments

History of legislations

The LBMs are essentially operated in the form of liberal practice structures (***). 

Decree of ****: in order to find a balance between the need for financing and professional independence, this decree :

Limits the holding of capital and voting rights authorized to non-biologists to **%; Limits the participation of non practising ...

5.2 General regulations

Constraints to the installation:

The professional must have a State diploma of Doctor of Medicine or Pharmacy as well as a Diploma of Specialized Studies in Medical Biology.

To set up a company, the majority of the capital must be held by one or more biologists in charge of the company ...


To keep reading, buy the full research

What is in this market study?

  • What are the figures on the size and growth of the market?
  • What is driving the growth of the market and its evolution?
  • What are the latest trends in this market?
  • What is the positioning of companies in the value chain?
  • How do companies in the market differ from each other?
  • Access company mapping and profiles.
  • Data from several dozen databases

  • This market study is available online and in pdf format (30 p.)
  • Consult an example PDF or online

Our other products

Our other products

Pack 5 études (-15%) - France

378 €

  • 5 études au prix de 75,6€HT par étude à choisir parmi nos 800 titres sur le catalogue France pendant 12 mois
  • Conservez -15% sur les études supplémentaires achetées
  • Choisissez le remboursement des crédits non consommés au terme des 12 mois (durée du pack)

Consultez les conditions du pack et de remboursement des crédits non consommés.



Analysts 1 sector analyzed
in 40 pages


  • Top Universities
  • Expert opinion


  • Databases
  • Press
  • Company reports


  • Continuously updated
  • Permanent watch


  • Synthetic structure
  • Standardized charts

Reviews (3)

Reviews (3)

The Insulin Pump Market - France

Publicado en 11/01/2022 by Amaury Wernert

A very precise and detailed study of this market, driven by the strong growth of this disease in the world

Businesscoot Response:

Hello Amaury, Thank you for your feedback. We are happy to read that the content of the study has fully met your expectations. :)

The dental implant market - France

Publicado en 07/01/2022 by Denis Monnoyeur

The study highlights three trends: the dynamism of the market, the concentration of players and the practice of high prices.

Businesscoot Response:

Hello Denis, Thank you very much for this very positive review! We are delighted to see that you appreciate our studies and we thank you for the trust you have placed in us.

The Parapharmacy Market - France

Publicado en 07/01/2022 by Client anonyme - Ce client a souhaité rester anonyme

Clear and concise generic study. Well documented. However, I would have liked to see that the actors' files at the end of the report corresponded precisely to those stated in the report.

Businesscoot Response:

Hello, Thank you for your feedback on our study. We are planning to update it taking into account your remarks, we will keep you informed as soon as it is available.

Customer cases and references

Customer cases and references
La pépite Interview
Linkedin logo

BFM Business

La pépite Interview

Paul-Alexis Kebabtchieff
Linkedin logo

Boston Consulting Group

Paul-Alexis Kebabtchieff

Marie Guibart
Linkedin logo

Kea Partners

Marie Guibart

Elaine, Durand
Linkedin logo

Crédit Agricole, Information & Veille

Elaine, Durand

Philippe Dilasser
Linkedin logo

Initiative & Finance

Philippe Dilasser

Anne Baudry
Linkedin logo


Anne Baudry

Amaury Wernert
Linkedin logo

Kroll (Duff & Phelps)

Amaury Wernert

Smart Leaders Interview
Linkedin logo


Smart Leaders Interview